[1]
Stropuvienė, S. et al. 2018. The impact of anti-cyclic citrullinated peptide antibody status on the management of patients with early rheumatoid arthritis: observational study results from Lithuania. Acta medica Lituanica. 25, 2 (Aug. 2018), 112–123. DOI:https://doi.org/10.6001/actamedica.v25i2.3765.